Sino Biopharmaceutical Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sino Biopharmaceutical Limited with three other
companies in this sector in Hong Kong:
The United Laboratories International Holdings Limited
sales of 7.90 billion Hong Kong Dollars [US$1.01 billion]
of which 42%
was Bulk Medicine),
CSPC Pharmaceutical Group Ltd
(15.46 billion Hong Kong Dollars [US$1.97 billion]
of which 74%
was Finished Drugs), and
China Traditional Chinese Medicine Holdings Co Ltd
(9.65 billion Hong Kong Dollars [US$1.23 billion]
of which 66%
was Concentrated TCM Granules).
During the year ended December of 2017, sales at
Sino Biopharmaceutical Limited were HK$17.15 billion (US$2.18 billion).
increase of 8.4%
versus 2016, when the company's sales were HK$15.83 billion.
This was the fifth consecutive year of sales increases at Sino Biopharmaceutical Limited
(and since 2012, sales have increased a total of 106%).
Sales of Modernized Chinese Medicines and Chemica saw an increase
8.7% in 2017, from
HK$15.30 billion to HK$16.63 billion.
Not all segments of Sino Biopharmaceutical Limited experienced an increase in sales in 2017:
sales of Others fell 1.0% to HK$521.29 million.
(However, this segment's sales were only a very small portion of the company's overall sales).